Maverick Therapeutics' Series B Round

Maverick Therapeutics raised a round of funding on January 11, 2017. Investors include MPM Capital.

Maverick Therapeutics is a private start-up biotechnology company. Maverick's novel T-cell engagement format has the potential to eliminate the toxicity challenges inherent in the use of T-cell redire…

Articles about Maverick Therapeutics' Series B Round: